Dentons Hong Kong's corporate finance team recently represented China International Capital Corporation Hong Kong Securities Limited and Jefferies Hong Kong Limited in connection with the IPO listing of Sisram Medical Ltd., the first ever Israeli company to list on Hong Kong Stock Exchange.

The global offering of 110,000,000 shares seeks to raise approximately US$200 million. The company published its Hong Kong prospectus on 5 September 2017. Dealings in the shares on the Hong Kong Stock Exchange commenced on 19 September 2017.

Sisram Medical Ltd. (Sisram) is a leading global provider of energy-based medical aesthetic treatment systems. Incorporated in Israel in 2013 as a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to acquire Alma Lasers Ltd., Sisram focuses on the design, development and production of energy-based medical aesthetic treatment systems. Sisram will become the first Israeli company to list on the Hong Kong Stock Exchange.

The Dentons Hong Kong team, acting as the joint sponsors and underwriters' legal counsel was led by Gordon Ng, Guangqin Wei and Enoch Wong.